Literature DB >> 25734378

Epigenetic Mechanisms of Serotonin Signaling.

Terrell Holloway1, Javier González-Maeso1.   

Abstract

Histone modifications and DNA methylation represent central dynamic and reversible processes that regulate gene expression and contribute to cellular phenotypes. These epigenetic marks have been shown to play fundamental roles in a diverse set of signaling and behavioral outcomes. Serotonin is a monoamine that regulates numerous physiological responses including those in the central nervous system. The cardinal signal transduction mechanisms via serotonin and its receptors are well established, but fundamental questions regarding complex interactions between the serotonin system and heritable epigenetic modifications that exert control on gene function remain a topic of intense research and debate. This review focuses on recent advances and contributions to our understanding of epigenetic mechanisms of serotonin receptor-dependent signaling, with focus on psychiatric disorders such as schizophrenia and depression.

Entities:  

Keywords:  G protein-coupled receptors (GPCRs); Schizophrenia; antipsychotics; epigenetics; hallucinogens; histone deacetylases (HDACs); lysergic acid diethylamide (LSD); psychosis; serotonin 5-HT2A receptor

Mesh:

Substances:

Year:  2015        PMID: 25734378      PMCID: PMC4838281          DOI: 10.1021/acschemneuro.5b00033

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  123 in total

1.  Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors.

Authors:  J C Gewirtz; G J Marek
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

Review 2.  Chromatin proteins and modifications as drug targets.

Authors:  Kristian Helin; Dashyant Dhanak
Journal:  Nature       Date:  2013-10-24       Impact factor: 49.962

3.  A physical map of the human genome.

Authors:  J D McPherson; M Marra; L Hillier; R H Waterston; A Chinwalla; J Wallis; M Sekhon; K Wylie; E R Mardis; R K Wilson; R Fulton; T A Kucaba; C Wagner-McPherson; W B Barbazuk; S G Gregory; S J Humphray; L French; R S Evans; G Bethel; A Whittaker; J L Holden; O T McCann; A Dunham; C Soderlund; C E Scott; D R Bentley; G Schuler; H C Chen; W Jang; E D Green; J R Idol; V V Maduro; K T Montgomery; E Lee; A Miller; S Emerling; R Gibbs; S Scherer; J H Gorrell; E Sodergren; K Clerc-Blankenburg; P Tabor; S Naylor; D Garcia; P J de Jong; J J Catanese; N Nowak; K Osoegawa; S Qin; L Rowen; A Madan; M Dors; L Hood; B Trask; C Friedman; H Massa; V G Cheung; I R Kirsch; T Reid; R Yonescu; J Weissenbach; T Bruls; R Heilig; E Branscomb; A Olsen; N Doggett; J F Cheng; T Hawkins; R M Myers; J Shang; L Ramirez; J Schmutz; O Velasquez; K Dixon; N E Stone; D R Cox; D Haussler; W J Kent; T Furey; S Rogic; S Kennedy; S Jones; A Rosenthal; G Wen; M Schilhabel; G Gloeckner; G Nyakatura; R Siebert; B Schlegelberger; J Korenberg; X N Chen; A Fujiyama; M Hattori; A Toyoda; T Yada; H S Park; Y Sakaki; N Shimizu; S Asakawa; K Kawasaki; T Sasaki; A Shintani; A Shimizu; K Shibuya; J Kudoh; S Minoshima; J Ramser; P Seranski; C Hoff; A Poustka; R Reinhardt; H Lehrach
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

Review 4.  Neurodevelopmental origins of depressive disorders.

Authors:  Mark S Ansorge; René Hen; Jay A Gingrich
Journal:  Curr Opin Pharmacol       Date:  2006-12-21       Impact factor: 5.547

5.  HDAC2 as a new target to improve schizophrenia treatment.

Authors:  Mitsumasa Kurita; Terrell Holloway; Javier González-Maeso
Journal:  Expert Rev Neurother       Date:  2013-01       Impact factor: 4.618

6.  Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia.

Authors:  Hans Rasmussen; David Erritzoe; Rune Andersen; Bjorn H Ebdrup; Bodil Aggernaes; Bob Oranje; Jan Kalbitzer; Jacob Madsen; Lars H Pinborg; William Baaré; Claus Svarer; Henrik Lublin; Gitte M Knudsen; Birte Glenthoj
Journal:  Arch Gen Psychiatry       Date:  2010-01

7.  Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth.

Authors:  Fanny Duhr; Paul Déléris; Fabrice Raynaud; Martial Séveno; Séverine Morisset-Lopez; Clotilde Mannoury la Cour; Mark J Millan; Joël Bockaert; Philippe Marin; Séverine Chaumont-Dubel
Journal:  Nat Chem Biol       Date:  2014-06-01       Impact factor: 15.040

8.  An epigenetic blockade of cognitive functions in the neurodegenerating brain.

Authors:  Johannes Gräff; Damien Rei; Ji-Song Guan; Wen-Yuan Wang; Jinsoo Seo; Krista M Hennig; Thomas J F Nieland; Daniel M Fass; Patricia F Kao; Martin Kahn; Susan C Su; Alireza Samiei; Nadine Joseph; Stephen J Haggarty; Ivana Delalle; Li-Huei Tsai
Journal:  Nature       Date:  2012-02-29       Impact factor: 49.962

Review 9.  Mapping recently identified nucleotide variants in the genome and transcriptome.

Authors:  Chun-Xiao Song; Chengqi Yi; Chuan He
Journal:  Nat Biotechnol       Date:  2012-11       Impact factor: 54.908

10.  Beyond genotype: serotonin transporter epigenetic modification predicts human brain function.

Authors:  Yuliya S Nikolova; Karestan C Koenen; Sandro Galea; Chiou-Miin Wang; Marianne L Seney; Etienne Sibille; Douglas E Williamson; Ahmad R Hariri
Journal:  Nat Neurosci       Date:  2014-08-03       Impact factor: 24.884

View more
  9 in total

1.  Differences in 5-HT2A and mGlu2 Receptor Expression Levels and Repressive Epigenetic Modifications at the 5-HT2A Promoter Region in the Roman Low- (RLA-I) and High- (RHA-I) Avoidance Rat Strains.

Authors:  Luna Fomsgaard; Jose L Moreno; Mario de la Fuente Revenga; Tomasz Brudek; Dea Adamsen; Cristobal Rio-Alamos; Justin Saunders; Anders Bue Klein; Ignasi Oliveras; Toni Cañete; Gloria Blazquez; Adolf Tobeña; Albert Fernandez-Teruel; Javier Gonzalez-Maeso; Susana Aznar
Journal:  Mol Neurobiol       Date:  2017-03-06       Impact factor: 5.590

Review 2.  Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation.

Authors:  S Brummelte; E Mc Glanaghy; A Bonnin; T F Oberlander
Journal:  Neuroscience       Date:  2016-02-22       Impact factor: 3.590

3.  Training Lymnaea in the presence of a predator scent results in a long-lasting ability to form enhanced long-term memory.

Authors:  Jeremy Forest; Hiroshi Sunada; Shawn Dodd; Ken Lukowiak
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2016-04-30       Impact factor: 1.836

4.  Stress exposure and psychopathology alter methylation of the serotonin receptor 2A (HTR2A) gene in preschoolers.

Authors:  Stephanie H Parade; Andrew M Novick; Justin Parent; Ronald Seifer; Samantha J Klaver; Carmen J Marsit; Asi Polly Gobin; Bao-Zhu Yang; Audrey R Tyrka
Journal:  Dev Psychopathol       Date:  2017-12

5.  Contribution of histone acetylation to the serotonin-mediated long-term synaptic plasticity in terrestrial snails.

Authors:  Alena B Zuzina; Pavel M Balaban
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2022-08-09       Impact factor: 2.389

Review 6.  N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.

Authors:  Edward James; Joachim Keppler; Thomas L Robertshaw; Ben Sessa
Journal:  Hum Psychopharmacol       Date:  2022-02-17       Impact factor: 2.130

Review 7.  Could use of Selective Serotonin Reuptake Inhibitors During Lactation Cause Persistent Effects on Maternal Bone?

Authors:  Samantha R Weaver; Laura L Hernandez
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-03-30       Impact factor: 2.673

8.  Special Issue Introduction: Role of Epigenetic Gene Regulation in Brain Function.

Authors:  Dennis R Grayson
Journal:  Genes (Basel)       Date:  2017-07-13       Impact factor: 4.096

Review 9.  Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics.

Authors:  Emmanuelle A D Schindler; Ryan M Wallace; Jordan A Sloshower; Deepak C D'Souza
Journal:  Front Pharmacol       Date:  2018-03-01       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.